ANIDRACTIV®
TARGETING CELLULAR SENESCENCE
A pioneering enzymatic biotechnology platform designed to target the core mechanisms of skin aging.
By reprogramming tissue pathways, Anidractiv triggers profound molecular regeneration and restores the skin’s ultimate structural integrity
PIEMMEGGI is an advanced biotechnology company dedicated to the discovery and development of innovative enzymatic complexes to combat cellular senescence.
Driven by our proprietary platform, ANIDRACTIV®, our primary focus is on deep tissue regeneration and skin longevity. We aim to reverse the signs of severe skin aging and the loss of viscoelasticity, while providing breakthrough solutions for complex structural and inflammatory conditions, including scars, post-acne scarring, dermatitis, and psoriasis.
We believe that our highly scientific and disruptive approach will open a new frontier in biotech-based regenerative solutions, restoring structural integrity and enabling people to preserve cellular youth over time.
Achieving this mission requires an extraordinary interdisciplinary effort, which is guaranteed by the robust scientific expertise within our company and our elite network of international partners.
Founded on Paolo Piazzetta’s vision in computational chemistry, we are a collective of experts in molecular sciences and venture capital.
We may succeed or fail, but guided by integrity and respect, we do things the right way. We are here to achieve what others deem impossible.
From computational chemistry (in silico) to clinical evidence (in vivo).
The Anidractiv platform translates our rigorous research models into real, safe solutions for tissue reprogramming and skin longevity
PIEMMEGGI Srl
Via Coschi 11
88046 Lamezia Terme (CZ)
P.IVA: 03566180794
CONTACTS
email: in**@*******gi.it